Cargando…

Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is characterized as a chronic, multifactorial disease and is the leading cause of irreversible blindness. Advanced AMD is classified as neovascular (wet) AMD and non-neovascular (dry) AMD. Dry AMD can progress to a more advanced form that manifests as geographi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Hannah, Aziz, Aamir A, Sulahria, Humza, Khan, Huma, Ahmed, Abrahim, Choudhry, Netan, Narayanan, Raja, Danzig, Carl, Khanani, Arshad M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892637/ https://www.ncbi.nlm.nih.gov/pubmed/36741078 http://dx.doi.org/10.2147/OPTH.S367089

Ejemplares similares

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020)

Effects of subthreshold nanosecond laser therapy in age-related macular degeneration using artificial intelligence (STAR-AI Study)
por: Hanna, Verina, et al.
Publicado: (2021)

Challenges in studying geographic atrophy (GA) age-related macular degeneration: the potential of a new mouse model with GA-like features
por: Ratnayaka, J. Arjuna, et al.
Publicado: (2019)

CLINICOPATHOLOGIC CORRELATION OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
por: Li, Miaoling, et al.
Publicado: (2019)

Manual Versus Semi-Automated Measurement of Geographic Atrophy Area in Eyes With Age-Related Macular Degeneration
por: Mahmoudzadeh, Raziyeh, et al.
Publicado: (2021)

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration
por: Khanani, Arshad M
Publicado: (2015)

Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Künzel, Sandrine H., et al.
Publicado: (2020)

Retinal Vessel Density in Age-Related Macular Degeneration Patients with Geographic Atrophy
por: Hong, Suji, et al.
Publicado: (2022)

RANTES (CCL5) in Patients With Geographic Atrophy Age-Related Macular Degeneration
por: Fonteh, Cheryl N., et al.
Publicado: (2023)

Geographic Atrophy in Age-Related Macular Degeneration: A Tale of Two Stages
por: Keenan, Tiarnan D.L.
Publicado: (2023)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
por: Borchert, Grace A., et al.
Publicado: (2023)

Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review
por: Arya, Malvika, et al.
Publicado: (2018)

HISTOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Multilayer Approach
por: Li, Miaoling, et al.
Publicado: (2018)

Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression
por: Thiele, Sarah, et al.
Publicado: (2021)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
por: Abdin, Alaa Din, et al.
Publicado: (2023)

Macular Telangiectasia Type 2: A Comprehensive Review
por: Kedarisetti, Kiran Chandra, et al.
Publicado: (2022)

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
por: Khanani, Arshad M., et al.
Publicado: (2023)

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration
por: Sakurada, Yoichi, et al.
Publicado: (2016)

Clinical and Genetic Factors Associated with Progression of Geographic Atrophy Lesions in Age-Related Macular Degeneration
por: Grassmann, Felix, et al.
Publicado: (2015)

Systemic expression of Alu RNA in patients with geographic atrophy secondary to age-related macular degeneration
por: Yoshida, Hiroyuki, et al.
Publicado: (2019)

Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration
por: Lashkari, Kameran, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Kim, Ashley, et al.
Publicado: (2021)

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Khanani, Arshad M., et al.
Publicado: (2018)

Utilization of deep learning to quantify fluid volume of neovascular age-related macular degeneration patients based on swept-source OCT imaging: The ONTARIO study
por: Sodhi, Simrat K., et al.
Publicado: (2022)

Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects
por: Danis, Ronald P, et al.
Publicado: (2015)

THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
por: Boyer, David S., et al.
Publicado: (2017)

Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study
por: Ruiz-Moreno, José M., et al.
Publicado: (2020)

Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions
por: Keenan, Tiarnan D.L.
Publicado: (2021)

C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration
por: Yednock, Ted, et al.
Publicado: (2022)

Interleukin-4 Plasma Levels Stratified by Sex in Intermediate Age-Related Macular Degeneration and Geographic Atrophy
por: Rajeswaren, Vivian, et al.
Publicado: (2023)

Use of Fundus Autofluorescence Combined with Optical Coherence Tomography for Diagnose of Geographic Atrophy in Age-Related Macular Degeneration
por: Massamba, Nathalie, et al.
Publicado: (2019)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Halawa, Omar A., et al.
Publicado: (2021)

Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?
por: Cruz-Pimentel, Miguel, et al.
Publicado: (2023)

Rehabilitation Methods for Patients with Geographic Atrophy due to Age-Related Macular Degeneration and Effects of Rehabilitation on Quality of Life
por: Erginturk Acar, Damla, et al.
Publicado: (2023)

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Kaiser, Peter K., et al.
Publicado: (2021)

Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
por: Nebbioso, Marcella, et al.
Publicado: (2019)

Chemokine Profile and the Alterations in CCR5-CCL5 Axis in Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Krogh Nielsen, Marie, et al.
Publicado: (2020)

Analyzing Age-Related Macular Degeneration Progression in Patients with Geographic Atrophy Using Joint Autoencoders for Unsupervised Change Detection
por: Dupont, Guillaume, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nl13qsb8hck5kbfq4ghgeqa4d0